In fact, galectin-3 interacts with FGFR (47), TGF-R (48), Notch1 (49, 50), MUC1 (51), and integrins (52), and triggers a variety of signalings, which may be of great advantage for tumor progression. The gene discussed is MUC1; the disease is neoplasm.